Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-09-20 | 2024-06 | 0 | N/A | N/A | N/A |
2024-07-01 | 2024-03 | 0 | N/A | N/A | N/A |
2023-02-28 | 2022-12 | -0.19 | N/A | N/A | N/A |
2022-11-08 | 2022-09 | -0.25 | -0.2 | 0.05 | 20.00% |
2022-08-15 | 2022-06 | -0.23 | -0.31 | -0.08 | -34.78% |
2022-05-05 | 2022-03 | 0 | N/A | N/A | N/A |
Date | Firm | Action | From | To |
---|---|---|---|---|
2022-11-02 | Cantor Fitzgerald | Upgrade | Overweight | |
2022-03-25 | HC Wainwright & Co. | Upgrade | Buy | |
2021-08-09 | HC Wainwright & Co. | Upgrade | Buy | |
2021-01-21 | Alliance Global Partners | Upgrade | Buy | |
2020-07-31 | HC Wainwright & Co. | Upgrade | Buy | |
2020-05-26 | Dawson James | Upgrade | Buy |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2018-09-12 | ABG MANAGEMENT, LTD. | Beneficial Owner of more than 10% of a Class of Security | 0.00 | Sale |
2021-03-15 | ASGHAR NAJJAM | Chief Financial Officer | 56.97K | Stock Award(Grant) |
2018-01-23 | ASIA PACIFIC MEDTECH BVI, LTD. | Beneficial Owner of more than 10% of a Class of Security | 8.62M | Sale |
2020-12-15 | FOLLOWWILL DORMAN | Director | 2.13K | Sale |
2021-12-26 | JANDA KIM D | Director | 3.00K | Sale |
2022-12-20 | JI HENRY H | Chief Executive Officer | 0.00 | Conversion of Exercise of derivative security |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2022-12-30 | State Street Corporation | 50.64M | 15.56M | 10.73% |
2022-12-30 | Blackrock Inc. | 39.42M | 12.11M | 8.35% |
2022-12-30 | Vanguard Group, Inc. (The) | 29.54M | 9.08M | 6.26% |
2022-12-30 | Geode Capital Management, LLC | 8.91M | 2.74M | 1.89% |
2022-12-30 | B. Riley Financial, Inc. | 5.22M | 1.60M | 1.11% |
2022-12-30 | B. Riley Securities, Inc. | 5.22M | 1.60M | 1.11% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2022-12-30 | SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF | 40.89M | 12.56M | 8.66% |
2022-09-29 | Vanguard Total Stock Market Index Fund | 12.84M | 3.95M | 2.72% |
2022-12-30 | iShares Russell 2000 ETF | 10.36M | 3.18M | 2.20% |
2022-09-29 | Vanguard Extended Market Index Fund | 5.51M | 1.69M | 1.17% |
2022-12-30 | Direxion Shares ETF Tr-Direxion Daily S&P Biotech Bull 3x Sh | 4.27M | 1.31M | 0.91% |
2022-12-30 | iShares Russell 2000 Value ETF | 4.11M | 1.26M | 0.87% |
Split | Date |
---|---|
0.04 : 1 | 2013-08-01 |
0.1 : 1 | 2008-10-07 |
-
Totally over reacting. I remember that NIO stock price dropped so much when they let its CFO go. The new CFO changed the game and NIO SP had a great run within a few months from $3 to $14.3 now! SRNE has so much going for it! Potential good news are coming in many dimensions. I am adding more .
-
CNN... Wolf Biltzer... (6:11pm) better saliva test may be available within weeks.
-
-
-
-
-
-
-
From Columbia research:
In summary, we developed HP-LAMP, which enables rapid detection of SARS-CoV-2 directly from saliva in 30 min using a simple one-step protocol with a LoD of 2 viral copies per L of saliva and a sensitivity and specificity of 97% and 100%, respectively. Performing the assay requires only a heat block and a 1.5 mL microcentrifuge tube prefilled with a mixture containing the necessary enzymes, primers, buffers and reagents to simultaneously perform reverse transcription and amplification of the SARS-CoV- 2 viral RNA, while blocking the naturally occurring inhibitors and nucleases found in saliva. This simple method can be easily scaled and deployed to centralized laboratories, points-of-care and field locations where testing is greatly needed.
Acknowledgement
We thank Drs. Kevin Roth, Steven Spitalnik, and Eldad Hod of the Department of Pathology and Cell Biology and members of the Williams Laboratory, Columbia University Fertility Center, Suh Laboratory, Clinical Microbiology Laboratory, Columbia University Laboratory of Personalized Genomic Medicine at Columbia University Medical Center and New York Presbyterian Hospital for their helpful inputs and support for this study. This study is supported by NIH grants R01HD100013 (Z.W.), -
Here is the link to Columbia spit test study:
https://www.medrxiv.org/content/10.1101/2020.06.13.20129841v1.full.pdf
-
$SRNE Is the party over?
-
-
Hope it’s approved tomorrow
-
Taking half of my profit just in case!
Below are my lucky charm as well
IBIO
BOXL
MRNA
BNTX
ABUS -
Bought 2000
-
-
-
This explains very well what happened: